OncoTargets and Therapy · 2016 · 17 citations · 14 references
MedicineMolecular BiologyOncologyCell DivisionMolecular OncologyOncogenesCancer ProgressionCell Cycle SignalingCell-cycle CheckpointsCell-cycle DysregulationCyclin-dependent KinasesProstate CancerCell Cycle DynamicsCell Cycle InhibitionCell Cycle InhibitorsG1 Phase ControlG1 TransitionG1-s Phase TransitionG1/s TransitionP21 Regulation
Prostate cancer (PC) is one of the leading causes of cancer death in men, and thus, finding new regulators is critical for PC therapy. Prostate and breast cancer overexpressed 1 (PBOV1) is overexpressed in breast, prostate, and bladder cancers, as it is upregulated in the serum of patients with PC, but the role of PBOV1 in PC has not been studied. In this article, we found that PBOV1 was indeed overexpressed in PC cells; PBOV1 overexpression promoted cell proliferation and colony formation ability and arrested cell cycle in the G0/G1 phase and tumorigenicity ability in vitro, whereas knockdown of PBOV1 reduced these effects. Further analysis of PBOV1 overexpression inhibited cell cycle inhibitors, P21 and P27, and increased the phosphorylation level of Rb and cyclin D1 expression, suggesting that PBOV1 promoted cell proliferation through promoting G1/S transition.
14
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller, Letícia Nogueira, Angela B. Mariotto et al. · CA A Cancer Journal for Clinicians · 2019 · 4.4K citations · Full text
Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer
Xiaodong Sun, Henry F. Frierson, Ceshi Chen et al. · Nature Genetics · 2005 · 183 citations